The effect of intrapartum magnesium sulfate therapy on fetal cardiac troponin I levels at delivery

References

• CoudreyL. The troponins.Arch InternMed 1998;158:1173–80
   PubMedGoogle Scholar
• Makikallio KVO, Jouppila P, Rasanen J. Ultrasonic and biochemical markers of human fetal cardiac dysfunction in placental insufficiency.Circulation 2002;105:2058–63
   Google Scholar
• Chaiworapongsa TEJ, Yoshimatsu J, Kalache K, et al. Subclinical myocardial injury in small for gestational age neonates. J Matern Fetal Neonat Med 2002;11:1–5
   Google Scholar
• Makikallio K, Vuolteenaho O, Jouppila P, et al. Association of severe placental insufficiency and systemic venous pressure rise in the fetus with increased neonatal cardiac troponin T levels. Am J Obstet Gynecol 2000;183:726–31
   PubMed Web of Science ®Google Scholar
• Moller JC, Thielsen B, Schaible TF, et al. Value of myocardial hypoxia markers (creatine kinase and its MB-fraction, troponin-T, QT-intervals) and serum creatinine for the retrospective diagnosis of perinatal asphyxia. Biol Neonate 1998;73:367–74
   PubMedGoogle Scholar
• Fleming SM, O�Gorman T, O�Byrne L, et al. CardiactroponinI and N-terminal pro-brain natriuretic peptide in umbilical artery blood in relationto fetal heart rate abnormalitiesduring labor. Pediatr Cardiol 2001;22:393–6
   PubMed Web of Science ®Google Scholar
• Clark SJ, Newland P, YoxallCW, et al. Cardiac troponin T in cord blood. Arch Dis Child Fetal Neonat Ed 2001;84:F34–7
   PubMed Web of Science ®Google Scholar
• Shelton SD, Fouse BL, Holleman CM, et al. Cardiac troponin T levels in umbilical cord blood. Am J Obstet Gynecol 1999; 181:1259–62
   PubMed Web of Science ®Google Scholar
• Mittendorf R, Covert R, Boman J, et al. Is tocolyticmagnesium sulphate associated with increased total paediatric mortality? Lancet 1997;350:1517–18
   PubMed Web of Science ®Google Scholar
• Adamcova M, Kokstein Z, Palicka V, et al. Troponin T levels in the cord blood of healthy term neonates. Physiol Res 1995; 44:99–104
   PubMed Web of Science ®Google Scholar
• Witlin AG, Sibai BM. Magnesium sulfate therapy in preeclampsia and eclampsia. Obstet Gynecol 1998;92:883–9
   PubMed Web of Science ®Google Scholar
• Hallak M, Berry SM, Madincea F, et al. Fetal serum and amniotic fluidmagnesiumconcentrationswithmaternal treatment. Obstet Gynecol 1993;81:185–8
   PubMed Web of Science ®Google Scholar
• Hallak M, Martinez-Poyer J, Kruger ML, et al. The effect of magnesium sulfate on fetal heart rate parameters: a randomized, placebo-controlled trial. Am J Obstet Gynecol 1999; 181:1122–7
   PubMed Web of Science ®Google Scholar
• Hamersley SL, Landy HJ, O�Sullivan MJ. Fetal bradycardia secondary to magnesium sulfate therapy for preterm labor. A case report. J Reprod Med 1998;43:206–10
   Google Scholar
• Chestnut DH, Thompson CS, McLaughlin GL, et al. Does the intravenous infusion of ritodrine or magnesium sulfate alter the hemodynamic response to hemorrhage in gravid ewes? Am J Obstet Gynecol 1988;159:1467–73
   PubMed Web of Science ®Google Scholar
• de Haan HH, Gunn AJ, Williams CE, et al. Magnesiumsulfate therapy during asphyxia in near-term fetal lambs does not compromise the fetus but does not reduce cerebral injury.Am J Obstet Gynecol 1997;176:18–27
   PubMed Web of Science ®Google Scholar
• Moon PF, RamsayMM, Nathanielsz PW. Intravenousinfusion of magnesiumsulfate and regional redistributionof fetal blood flow during maternal hemorrhage in late-gestation gravid ewes. Am J Obstet Gynecol 1999;181:1486–94
   Google Scholar
• Reynolds JD, Chestnut DH, Dexter F, et al. Magnesiumsulfate adversely affects fetal lamb survival and blocks fetal cerebral blood flow response during maternal hemorrhage. Anesth Analg 1996;83:493–9
   PubMed Web of Science ®Google Scholar
• Caspi J, Coles JG, Benson LN, et al. Brain damage and myocardial dysfunction: protective effects of magnesium in the newborn pig. Ann Thorac Surg 1998;65:1730–6
   PubMed Web of Science ®Google Scholar
• CommitteeonTechnicalBulletinsof the AmericanCollege of Obstetricians and Gynecologists. Hypertension in Pregnancy. ACOG Technical Bulletin no. 219, January 1996. Int J Gynaecol Obstet 1996;53: 175–83
   Google Scholar
• Mittendorf R, Pryde P, Khoshnood B, et al. If tocolyticmagnesiumsulfate is associated with excess total pediatricmortality, what is its impact? Obstet Gynecol 1998;92:308–11
   PubMed Web of Science ®Google Scholar
• Mittendorf R, Pryde PG. An overview of the possible relationship between antenatal pharmacologic magnesium and cerebral palsy. J Perinat Med 2000;28:286–93
   PubMed Web of Science ®Google Scholar
• Martinez-Poyer JHM, King M, Bryant-Poole K, et al. Magnesiumsulfate effectonfetal left ventricularfunction.Arandomized, placebo controlled trial. J Soc Gynecol Invest 1999;6: A164–87
   Google Scholar
• Kamitomo M, Sameshima H, Ikenoue T, et al. Fetal cardiovascular function during prolonged magnesium sulfate tocolysis. J Perinat Med 2000;28:377–82
   PubMed Web of Science ®Google Scholar
• Shechter M, Hod H, Marks N, et al. Beneficial effect of magnesium sulfate in acute myocardial infarction. Am J Cardiol 1990;66:271–4
   PubMed Web of Science ®Google Scholar
• Teo KK, Yusuf S, Collins R, et al. Effectsof intravenousmagnesium in suspected acute myocardial infarction: overview of randomised trials. Br Med J 1991;303:1499–503
   PubMed Web of Science ®Google Scholar
• Iseri LT. Magnesium and cardiac arrhythmias. Magnesium 1986;5:111–26
   PubMedGoogle Scholar
• Vigorito C, Giordano A, Ferraro P, et al. Hemodynamic effects of magnesiumsulfateon the normal human heart.AmJ Cardiol 1991;67:1435–7
   PubMed Web of Science ®Google Scholar
• Apple FS. Tissue specificity of cardiac troponin I, cardiac troponin T and creatine kinase-MB. Clin Chim Acta 1999; a284:151–9
   Google Scholar
• Bodor GS, Survant L, Voss EM, et al. Cardiac troponin T composition in normal and regenerating human skeletal muscle. Clin Chem 1997;43:476–84
   PubMed Web of Science ®Google Scholar
• Arias F, Rodriquez L, Rayne SC, et al. Maternal placental vasculopathy and infection: two distinct subgroups among patients with pretermlabor and preterm rupturedmembranes. Am J Obstet Gynecol 1993;168:585–91
   PubMed Web of Science ®Google Scholar
• OttWJ. Intrauterine growth retardationand pretermdelivery. Am J Obstet Gynecol 1993;168:1710-15; discussion 1715–17
   Google Scholar
• Yoon BH, Romero R, Moon JB, et al. Clinical significance of intra-amniotic inflammation in patients with preterm labor and intactmembranes.AmJ Obstet Gynecol2001;185:1130–6
   Web of Science ®Google Scholar
• Gomez R, Romero R, Ghezzi F, et al. The fetal inflammatory response syndrome. Am J Obstet Gynecol 1998;179:194–202
   PubMed Web of Science ®Google Scholar
• Romero RGR, Ghezzi F, Maymon E, et al. A novel form of fetal cardiac dysfunction in preterm premature rupture of the membranes. Am J Obstet Gynecol 1999;180:S27
   Google Scholar
• ScudieroR, Khoshnood B, Pryde PG, et al. Perinatal death and tocolytic magnesium sulfate. Obstet Gynecol 2000;96:178–82
   PubMed Web of Science ®Google Scholar
• Mittendorf R, Dambrosia J, Dammann O, et al. Association between maternal serum ionized magnesiumlevels at delivery and neonatal intraventricular hemorrhage. J Pediatr 2002; 140:540–6
   PubMed Web of Science ®Google Scholar
• Mittendorf R, Covert R, Elin R, et al. Umbilical cord serum ionized magnesium level and total pediatric mortality. Obstet Gynecol 2001;98:75–8
   PubMed Web of Science ®Google Scholar
• Mittendorf R, Dambrosia J, Pryde PG, et al. Association between the use of antenatal magnesium sulfate in preterm labor and adverse health outcomes in infants. Am J Obstet Gynecol 2002;186:1111–18
   PubMed Web of Science ®Google Scholar